Daphne Koller.
Co-founder of Insitro
She pioneers the use of AI in drug discovery.
Her work bridges computer science and biotechnology.
In 1968, she was born in Israel.
In 1995, she earned her PhD in Computer Science from Stanford University.
In 2018, she co-founded Insitro.
1. AI-driven drug discovery, a method that uses machine learning to find new treatments.
2. It helps accelerate the development of medicines.
3. It supports precision therapies for complex diseases.
Her work transformed computational biology and pharma research.
She continues to innovate at the intersection of AI and medicine.
She currently serves as CEO of Insitro.
Want to know more stories?
Visit Daphne Koller.